32
14. Pierson TC, Diamond MS, Ahmed AA, Valentine LE, Davis CW, Samuel MA,
Hanna SL, Puffer BA, Doms RW: An infectious West Nile virus that
expresses a GFP reporter gene. Virology 2005, 334:28-40.
15. Harvey TJ, Liu WJ, Wang XJ, Linedale R, Jacobs M, Davidson A, Le TT,
Anraku I, Suhrbier A, Shi PY, Khromykh AA: Tetracycline-inducible
packaging cell line for production of flavivirus replicon particles. J Virol
2004, 78:531-538.
16. Tannis LL, Gauthier A, Evelegh C, Parsons R, Nyholt D, Khromykh A,
Bramson JL: Semliki forest virus and Kunjin virus RNA replicons elicit
comparable cellular immunity but distinct humoral immunity. Vaccine
2005, 23:4189-4194.
17. Westaway EG, Mackenzie JM, Khromykh AA: Kunjin RNA replication and
applications of Kunjin replicons. Adv Virus Res 2003, 59:99-140.
18. Jones CT, Patkar CG, Kuhn RJ: Construction and applications of yellow
fever virus replicons. Virology 2005, 331:247-259.
19. Mason PW, Shustov AV, Frolov I: Production and characterization of
vaccines based on flaviviruses defective in replication. Virology 2006,
351:432-443.
20. Allison SL, Stiasny K, Stadler K, Mandl CW, Heinz FX: Mapping of
functional elements in the stem-anchor region of tick-borne encephalitis
virus envelope protein E. J Virol 1999, 73:5605-5612.
21. Rey FA, Heinz FX, Mandl C, Kunz C, Harrison SC: The envelope
glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature
1995, 375:291-298.
22. Zhang W, Chipman PR, Corver J, Johnson PR, Zhang Y, Mukhopadhyay S,
Baker TS, Strauss JH, Rossmann MG, Kuhn RJ: Visualization of membrane
protein domains by cryo-electron microscopy of dengue virus. Nat Struct
Biol 2003, 10:907-912.
23. Mukhopadhyay S, Kuhn RJ, Rossmann MG: A structural perspective of the
flavivirus life cycle. Nat Rev Microbiol 2005, 3:13-22.
24. Op De Beeck A, Molenkamp R, Caron M, Ben Younes A, Bredenbeek P,
Dubuisson J: Role of the transmembrane domains of prM and E proteins in
the formation of yellow fever virus envelope. J Virol 2003, 77:813-820.
25. Cocquerel L, Wychowski C, Minner F, Penin F, Dubuisson J: Charged
residues in the transmembrane domains of hepatitis C virus glycoproteins
play a major role in the processing, subcellular localization, and assembly
of these envelope proteins. J Virol 2000, 74:3623-3633.
26. Higy M, Junne T, Spiess M: Topogenesis of membrane proteins at the
endoplasmic reticulum. Biochemistry 2004, 43:12716-12722.
27. Van Epps HL: Broadening the horizons for yellow fever: new uses for an old
vaccine. J Exp Med 2005, 201:165-168.
28. Guirakhoo F, Kitchener S, Morrison D, Forrat R, McCarthy K, Nichols R,
Yoksan S, Duan X, Ermak TH, Kanesa-Thasan N, et al: Live attenuated
chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: Phase I
clinical trial for safety and immunogenicity: effect of yellow fever pre-
immunity in induction of cross neutralizing antibody responses to all 4
dengue serotypes. Hum Vaccin 2006, 2:60-67.
29. Chambers TJ, Weir RC, Grakoui A, McCourt DW, Bazan JF, Fletterick RJ,
Rice CM: Evidence that the N-terminal domain of nonstructural protein
NS3 from yellow fever virus is a serine protease responsible for site-specific